Purdue Pharma, the pharmaceutical company responsible for OxyContin, has recently filed a new bankruptcy plan outlining a ...
Purdue Pharma asked a bankruptcy judge this week to consider the latest version of its plan to settle thousands of lawsuits ...
Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims ...
Purdue Pharma is seeking approval from a bankruptcy judge for its reorganization plan, which aims to dissolve the company and ...
Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of ...
Purdue Pharma headquarters at 201 Tresser Boulevard in Stamford. STAMFORD – Purdue Pharma L.P.’s owners will distribute about $7.5 billion ...
Purdue Pharma has submitted a revised Chapter 11 bankruptcy plan proposing more than $7.4 billion in cash payments to ...
By Dietrich Knauth NEW YORK (Reuters) -Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion ...
After a federal guilty plea in 2020, the former OxyContin drugmaker is required to reemerge from Chapter 11 bankruptcy as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results